Lori Freedman's most recent trade in Organogenesis Holdings Inc - Ordinary Shares - Class A was a trade of 142,379 Class A Common Stock done at an average price of $2.9 . Disclosure was reported to the exchange on June 4, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Organogenesis Holdings Inc... | Lori Freedman | Chief Admin. and Legal Officer | Purchase of securities on an exchange or from another person at price $ 2.91 per share. | 04 Jun 2025 | 142,379 | 837,437 (0%) | 0% | 2.9 | 413,625 | Class A Common Stock |
| Organogenesis Holdings Inc... | Lori Freedman | Chief Admin. and Legal Officer | Purchase of securities on an exchange or from another person at price $ 2.82 per share. | 04 Jun 2025 | 100,863 | 695,058 (0%) | 0% | 2.8 | 284,716 | Class A Common Stock |
| Organogenesis Holdings Inc... | Lori Freedman | Chief Admin. and Legal Officer | Purchase of securities on an exchange or from another person at price $ 2.99 per share. | 04 Jun 2025 | 9,022 | 846,459 (0%) | 0% | 3.0 | 26,949 | Class A Common Stock |
| Organogenesis Holdings Inc... | Lori Freedman | Chief Admin. and Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 167,625 | 167,625 | - | - | Stock Option (Right to Buy) | |
| Organogenesis Holdings Inc... | Lori Freedman | Chief Admin. and Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 162,047 | 594,195 (0%) | 0% | 0 | Class A Common Stock | |
| Organogenesis Holdings Inc... | Lori Freedman | Chief Admin. and Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.70 per share. | 15 Feb 2025 | 22,178 | 435,864 (0%) | 0% | 3.7 | 82,059 | Class A Common Stock |
| Organogenesis Holdings Inc... | Lori Freedman | Chief Admin. and Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.70 per share. | 15 Feb 2025 | 11,230 | 458,042 (0%) | 0% | 3.7 | 41,551 | Class A Common Stock |
| Organogenesis Holdings Inc... | Lori Freedman | Chief Admin. and Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.70 per share. | 15 Feb 2025 | 3,070 | 432,794 (0%) | 0% | 3.7 | 11,359 | Class A Common Stock |
| Organogenesis Holdings Inc... | Lori Freedman | Chief Admin. and Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.70 per share. | 15 Feb 2025 | 646 | 432,148 (0%) | 0% | 3.7 | 2,390 | Class A Common Stock |
| Organogenesis Holdings Inc... | Lori Freedman | Chief Admin. and Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.80 per share. | 01 Apr 2024 | 1,974 | 469,272 (0%) | 0% | 2.8 | 5,527 | Class A Common Stock |
| Organogenesis Holdings Inc... | Freedman Lori | Chief Admin. and Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 276,737 | 276,737 | - | - | Stock Option (Right to Buy) | |
| Organogenesis Holdings Inc... | Freedman Lori | Chief Admin. and Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 153,061 | 471,246 (0%) | 0% | 0 | Class A Common Stock | |
| Organogenesis Holdings Inc... | Freedman Lori | Chief Admin. and Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.68 per share. | 15 Feb 2024 | 21,516 | 322,474 (0%) | 0% | 3.7 | 79,179 | Class A Common Stock |
| Organogenesis Holdings Inc... | Lori Freedman | Chief Admin. and Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.68 per share. | 15 Feb 2024 | 3,643 | 318,831 (0%) | 0% | 3.7 | 13,406 | Class A Common Stock |
| Organogenesis Holdings Inc... | Lori Freedman | Chief Admin. and Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.48 per share. | 15 Feb 2024 | 646 | 318,185 (0%) | 0% | 3.5 | 2,248 | Class A Common Stock |
| Organogenesis Holdings Inc... | Lori Freedman | Chief Admin. and Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.13 per share. | 01 Apr 2023 | 2,339 | 343,990 (0%) | 0% | 2.1 | 4,982 | Class A Common Stock |
| Organogenesis Holdings Inc... | Lori Freedman | VP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2023 | 331,076 | 331,076 | - | - | Stock Option (Right to Buy) | |
| Organogenesis Holdings Inc... | Lori Freedman | VP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2023 | 278,884 | 346,329 (0%) | 0% | 0 | Class A Common Stock | |
| Organogenesis Holdings Inc... | Lori Freedman | VP and General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.92 per share. | 15 Feb 2023 | 3,635 | 68,210 (0%) | 0% | 2.9 | 10,614 | Class A Common Stock |
| Organogenesis Holdings Inc... | Lori Freedman | VP and General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.75 per share. | 15 Feb 2023 | 765 | 67,445 (0%) | 0% | 2.8 | 2,104 | Class A Common Stock |
| Organogenesis Holdings Inc... | Lori Freedman | VP and General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.89 per share. | 01 Apr 2022 | 2,984 | 71,845 (0%) | 0% | 7.9 | 23,544 | Class A Common Stock |
| Organogenesis Holdings Inc... | Lori Freedman | VP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 99,236 | 99,236 | - | - | Stock Option (Right to Buy) | |
| Organogenesis Holdings Inc... | Lori Freedman | VP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 41,843 | 75,594 (0%) | 0% | 0 | Class A Common Stock | |
| Organogenesis Holdings Inc... | Lori Freedman | VP and General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.78 per share. | 15 Feb 2022 | 765 | 74,829 (0%) | 0% | 7.8 | 5,952 | Class A Common Stock |
| Organogenesis Holdings Inc... | Lori Freedman | VP and General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.83 per share. | 01 Apr 2021 | 1,975 | 33,751 (0%) | 0% | 19.8 | 39,164 | Class A Common Stock |
| Organogenesis Holdings Inc... | Lori Freedman | VP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 67,444 | 67,444 | - | - | Stock Option (Right to Buy) | |
| Organogenesis Holdings Inc... | Lori Freedman | VP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 8,808 | 35,726 (0%) | 0% | 0 | Class A Common Stock |